Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.94 +0.00 (+0.00%)
As of: Oct 22, 2026 · 12:15 PM EDT

Polaryx Therapeutics (PLYX) EBIT (2025 - 2026)

Updated

Polaryx Therapeutics (PLYX) posted EBIT of -$1.38 million for Q2 2026, compared with -$884,000 a year earlier.

Analysis

Polaryx Therapeutics (PLYX) EBIT (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT at Polaryx Therapeutics was -$9.27 million; for FY2025, it was -$7.82 million.

  • In prior years, Polaryx Therapeutics' EBIT was -$4.35 million in FY2024.
  • Quarterly EBIT has run from a low of -$5.05 million in Q1 2025 to a high of -$884,000 in Q2 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn 7.14 Bn
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn 6.43 Bn
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn 3.16 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn -10.39 Bn
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn 4.27 Bn
10 Polaryx Therapeutics 91.25 Mn 66.86 Mn - -1.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.38 Mn
Mar 31, 2026 -1.96 Mn
Jun 30, 2025 -884,000.00
Mar 31, 2025 -5.05 Mn
API Access

Polaryx Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=PLYX&period=max&api_key=YOUR_API_KEY